Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2021 - 02 - 16 crawled time : 12:03 save search
ACCIONA and Plug Power to Partner on Establishing Leading Green Hydrogen Platform for Iberia
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
PLUG | $2.405 -7.14% -7.69% 38M
|
Electronic Technology
|
| O: 2.88%
H: 0.0%
C: -9.24%
hydrogen platform
XPO Logistics Awarded LTL Collaborator of the Year by GlobalTranz
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
XPO | $117.48 -2.78% 0.0% 2.7M
|
Transportation
|
| O: 1.6%
H: 1.41%
C: -0.45%
collaboration awards
Shockwave Intravascular Lithotripsy FDA Approved to Treat Advanced Heart Disease
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
SWAV | $328.56 0.01% 0.01% 1.4M
|
Health Technology
|
| O: 4.83%
H: 0.04%
C: -6.18%
disease fda heart disease heart approval fda approval
HOOKIPA Pharma to Participate in Upcoming SVB Leerink Global Healthcare Conference
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
HOOK | $0.843 10.2% 9.25% 10M
|
Health Technology
|
| O: 4.85%
H: 4.3%
C: 2.64%
svb leerink global pharma
Baudax Bio Reports 2020 Annual Financial Results
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -1.57%
H: 4.26%
C: -5.85%
financial results results report
Freeline Announces Expansion of Executive Leadership
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
FRLN | $6.48 0.0% 0
|
Health Technology
|
| O: 2.83%
H: 1.25%
C: -1.25%
expansion
Clene Nanomedicine Initiates Phase 2 Study of CNM-ZnAg for Patients with COVID-19
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
CLNN 4 | $0.3374 0.69% 0.68% 300K
|
|
| O: 0.56%
H: 31.37%
C: 29.78%
covid phase 2 covid-19
Sio Gene Therapies to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 0.3%
H: 3.92%
C: -0.6%
gene therapies svb leerink global therapy gene therapy
Neuronetics to Report Fourth Quarter and Fiscal Year 2020 Financial and Operating Results and Host Conference Call
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
STIM | $3.76 -2.59% -2.66% 21K
|
Health Technology
|
| O: 2.0%
H: 11.26%
C: 1.22%
results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.